Back to Search Start Over

Solvay's organic possibilities.

Authors :
Boswell, Clay
Source :
ICIS Chemical Business Americas; 10/2/2006, Vol. 270 Issue 12, p36-37, 2p, 2 Color Photographs
Publication Year :
2006

Abstract

The article highlights Solvay's plans of venturing into Cosmetics, electronics, energy conservation and renewable resources other than pharmaceuticals, that will need the development of substantial intellectual property. Solvay's Peptisyntha is ruling the market in the cGMP manufacture of peptides. Girindus manufactures oligonucleotides by both solid and liquid-phase synthesis.

Details

Language :
English
ISSN :
1936458X
Volume :
270
Issue :
12
Database :
Complementary Index
Journal :
ICIS Chemical Business Americas
Publication Type :
Periodical
Accession number :
22864579